+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

New drug applications; drug master files. Food and Drug Administration, HHS. Final rule



New drug applications; drug master files. Food and Drug Administration, HHS. Final rule



Federal Register 65(8): 1776-1780



The Food and Drug Administration (FDA) is revising its regulation governing drug master files (DMF's). FDA is removing the provision for submitting Type I DMF's and will no longer permit information submitted in a Type I DMF to be incorporated by reference in investigational new drug applications (IND's), new drug applications (NDA's), abbreviated new drug applications (ANDA's), or amendments or supplements to any of these. This rule is intended to eliminate submissions of information that are not necessary either to conduct inspections of manufacturing facilities or to review the chemistry, manufacturing, and controls sections of IND's, NDA's, and abbreviated applications.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046793598

Download citation: RISBibTeXText

PMID: 11010656


Related references

Delegations of authority and organization; new drug applications--Food and Drug Administration. Final rule. Federal Register 47(120): 26822-3, 1982

Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule. Federal Register 72(201): 58993-59000, 2007

Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Final rule. Federal Register 74(143): 37163-8, 2009

Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Direct final rule. Federal Register 73(189): 56487-56491, 2008

Investigational new drug applications; amendment to clinical hold regulations for products intended for life-threatening diseases and conditions. Food and Drug Administration, HHS. Final rule. Federal Register 65(106): 34963-34971, 2000

Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule. Federal Register 65(148): 46864-8, 2000

Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule. Federal Register 65(168): 52302-5, 2000

Sunscreen drug products for over-the-counter human use; final monograph. Food and Drug Administration, HHS. Final rule. Federal Register 64(98): 27666-27693, 1999

Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule. Federal Register 64(232): 67720-67763, 2000

Laxative drug products for over-the-counter human use. Food and Drug Administration, HHS. Final rule. Federal Register 64(19): 4535-4540, 1999

Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule. Federal Register 46(1): 28-30, 1980

Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule. Federal Register 45(179 Pt 2): 60754-60784, 1980

Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule. Federal Register 64(220): 62110-2, 2000

Sterility requirement for aqueous-based drug products for oral inhalation. Food and Drug Administration, HHS. Final rule. Federal Register 65(103): 34082-9, 2000

Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule. Federal Register 47(173): 39147-39155, 1982